1. Ammon, H. P. T. (1996). Salai Guggal-Boswellia serrata: From a herbal medicine to a non redox inhibitor of leukotriene biosynthesis. Eur J Med Res 1: 369–370.
2. Böker, D. K. & Winking, M. (1997). Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome. Deutsches Ärzteblatt 94: B958–B960.
3. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., McDonnell, T. J., Steck, P. A., Levin, V. A. & Yung, W. K. A. (1997). Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst 89: 1036–1044.
4. Gupta, I., Parihar, A., Malhotra, P., Singh, G. B., Lüdtke, R., Safayhi, H. & Ammon, H. P. T. (1997). Effects of boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2: 37–43.
5. Heldt, R. M., Syrovets, T., Winking, M., Sailer, E. R., Safayhi, H., Ammon, H. P. T. & Simmet, T. H. (1997). Boswellic acids exhibit cytotoxic effects on brain tumor cells independent from 5-lipoxygenase inhibition. Naunyn-S-Arch Pharmacol 355: 30 (Abstract)